Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders

8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders

US Patent 7951803 · Granted May 31, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Orally active melanocortin receptor-4 compounds2025
PTPRD inhibitors and uses thereof2024
Sting agonists for treating bladder cancer and solid tumors2024
Sting agonists for treating bladder cancer and solid tumors2024
Heterocycle amines and uses thereof2023
Heterocycle amines and uses thereof2023
Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, an2023
Non-systemic TGR5 agonists2022
Compounds, compositions, and methods for use in treating autophagy-associated di2021
Heterocycle amines and uses thereof2021
Heterocycle amines and uses thereof2021
Sting agonists2021